PCNL联合输尿管软镜与单纯PCNL治疗泌尿系结石的PRECISE随机对照试验方案
PRECISE是一项前瞻性、非盲、随机、平行组、多中心干预试验,比较内镜联合肾内手术(ECIRS,即PCNL联合逆行输尿管软镜)与标准PCNL在经皮肾结石手术患者中的疗效、安全性、结石相关疾病负担和资源利用。主要终点为术后4周CT评估的A级(0 mm)无石率。计划招募350例患者(每组175例),随访至术后5年。
要点
- PRECISE试验比较ECIRS与标准PCNL,主要终点为术后4周CT的A级无石率。
- 计划纳入350例成人经皮肾结石手术患者,1:1随机分组。
- 次要终点包括并发症、结石相关事件、生活质量、成本效益及环境影响。
核心结论
- PRECISE试验旨在评估ECIRS相比标准PCNL是否能提高无石率并降低结石相关疾病负担,同时评估资源利用和成本效益。
研究设计与样本
- 前瞻性、非盲、随机、平行组、多中心干预试验,计划招募350例(每组175例)适合经皮肾结石手术的成人患者,1:1随机分配至ECIRS或标准PCNL。
关键数值与推荐
- 主要终点为术后4周CT评估的A级(0 mm)无石率。
- 次要放射学终点包括术后4周B级(≤2 mm)和C级(≤4 mm)无石率、结石体积减少、1年无石率及辐射暴露。
- 其他结局包括并发症、手术时长、结石相关事件(SREs)、健康相关生活质量(HRQoL)、成本差异、成本效益及环境影响,随访至术后5年。
- 纳入标准为年龄≥18岁、适合经皮肾结石手术且逆行通路可行的患者;主要排除标准包括肾乳头钙化、肾移植和(疑似)妊娠。
临床怎么用
- 若ECIRS被证实优于标准PCNL,可为经皮肾结石手术的术式选择提供高级别证据,并指导资源分配。
局限性
- 试验为非盲设计,可能引入偏倚;成本效益和环境影响的评估为回顾性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Percutaneous nephrolithotomy (PCNL) often fails to achieve complete stone clearance with a single procedure. Residual fragments, irrespective of size, are associated with increased stone-related morbidity and a higher likelihood of re-intervention. Endoscopic combined intrarenal surgery (ECIRS), which integrates PCNL with retrograde ureterorenoscopy, may improve stone-free rates and reduce morbidity. However, given the potential for increased risks and greater resource utilisation, a comprehensive randomised controlled trial is warranted. The 'PRECISE' trial is designed to compare ECIRS and PCNL in terms of efficacy, safety, stone-related morbidity, and resource utilisation. STUDY DESIGN: The PRECISE is a prospective, non-blinded, randomised, parallel-group, multicentre interventional trial involving patients eligible for percutaneous kidney stone surgery. Patients will be randomised in a 1:1 ratio to undergo either ECIRS or standard PCNL. ENDPOINTS: The primary endpoint is the Grade A (0 mm) stone-free rate on postoperative computed tomography (CT) at 4 weeks. Secondary radiological endpoints include Grade B (≤2 mm) and Grade C (≤4 mm) stone-free rates at 4 weeks, stone volume reduction, 1-year stone-free rates, and radiation exposure. Additional outcomes include complications, operative duration, stone-related events (SREs), health-related quality of life (HRQoL), cost differences, cost-effectiveness and environmental impact, assessed up to 5 years postoperatively. PATIENTS AND METHODS: Adults (aged ≥18 years) eligible for percutaneous kidney stone surgery, where retrograde access is feasible, will be recruited. The main exclusion criteria comprise papillary calcifications, renal transplant procedures, and (suspected) pregnancy. A total of 350 patients (175 per arm) will be recruited. Follow-up includes CT imaging with clinical consultations at 4 weeks and 1 year to evaluate radiological outcomes, complications, SREs, and HRQoL. Telephone interviews at 3 and 5 years will assess long-term SREs and HRQoL. We aim to retrospectively evaluate cost differences, cost-effectiveness, and environmental impact. TRIAL REGISTRATION: The PRECISE study: an investigation into combined kidney stone surgery, Dutch Trial Registry, NL-009577.
引用
- Suijker CA, Kingma RA, Bakker D, et al. The benefits of PCNL combined with ureterorenoscopy compared to isolated PCNL in urolithiasis (PRECISE): a multicentre randomised controlled trial protocol. BJU Int. 2025. PMID: 40996103. doi:10.1111/bju.70008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。